Mallinckrodt launches Lisdexamfetamine Dimesylate Capsules for ADHD after FDA approval
The FDA has approved the firm’s ANDA for Lisdexamfetamine Dimesylate Capsules 10mg, 20mg, 30mg, 40mg, 50mg, 60mg, and…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
01 Sep 23
The FDA has approved the firm’s ANDA for Lisdexamfetamine Dimesylate Capsules 10mg, 20mg, 30mg, 40mg, 50mg, 60mg, and…
01 Sep 23
RELiZORB is the only enzyme product cleared by the FDA for use with enteral feeding
01 Sep 23
Bonchon, a global leader in fast-casual Asian fusion dining known for its distinctive Korean double-fried chicken, has appointed…
01 Sep 23
The ACTIMIS clinical trial evaluating glenzocimab in combination with the reference treatment in patients presenting with AIS has…
01 Sep 23
The piñata was designed by the Masa Collective and ACES HIGH and was awarded the record at the…
01 Sep 23
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Phase III ALINA study evaluating Alecensa® (alectinib), compared…
01 Sep 23
Huma said it expects the technology to automate its clinical summary reports and improve its data triaging processes.
01 Sep 23
Yum China Holdings, Inc. (NYSE: YUMC and HKEX: 9987, "Yum China" or the "Company") has unveiled a landmark…
01 Sep 23
The Hunger Action Month Campaign Urges Public to Join the Movement to End Hunger Through Donating, Volunteering or…
01 Sep 23
Interview with Alicia Martínez (PhD), CEO, Time is Brain